143 related articles for article (PubMed ID: 19405217)
1. Virulence mechanisms of Moraxella in the pathogenesis of infection.
Perez Vidakovics ML; Riesbeck K
Curr Opin Infect Dis; 2009 Jun; 22(3):279-85. PubMed ID: 19405217
[TBL] [Abstract][Full Text] [Related]
2. Moraxella catarrhalis: from interactions with the host immune system to vaccine development.
Su YC; Singh B; Riesbeck K
Future Microbiol; 2012 Sep; 7(9):1073-100. PubMed ID: 22953708
[TBL] [Abstract][Full Text] [Related]
3. Virulence factors of Moraxella catarrhalis outer membrane vesicles are major targets for cross-reactive antibodies and have adapted during evolution.
Augustyniak D; Seredyński R; McClean S; Roszkowiak J; Roszniowski B; Smith DL; Drulis-Kawa Z; Mackiewicz P
Sci Rep; 2018 Mar; 8(1):4955. PubMed ID: 29563531
[TBL] [Abstract][Full Text] [Related]
4. PRELP Enhances Host Innate Immunity against the Respiratory Tract Pathogen
Liu G; Ermert D; Johansson ME; Singh B; Su YC; Paulsson M; Riesbeck K; Blom AM
J Immunol; 2017 Mar; 198(6):2330-2340. PubMed ID: 28148731
[TBL] [Abstract][Full Text] [Related]
5. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
Enright MC; McKenzie H
J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
[TBL] [Abstract][Full Text] [Related]
6. Moraxella catarrhalis, a human respiratory tract pathogen.
Murphy TF; Parameswaran GI
Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579
[TBL] [Abstract][Full Text] [Related]
7. Moraxella-dependent alpha 1-antichymotrypsin neutralization: a unique virulence mechanism.
Manolov T; Tan TT; Forsgren A; Riesbeck K
Am J Respir Cell Mol Biol; 2008 May; 38(5):609-17. PubMed ID: 18096871
[TBL] [Abstract][Full Text] [Related]
8. Molecular aspects of Moraxella catarrhalis pathogenesis.
de Vries SP; Bootsma HJ; Hays JP; Hermans PW
Microbiol Mol Biol Rev; 2009 Sep; 73(3):389-406, Table of Contents. PubMed ID: 19721084
[TBL] [Abstract][Full Text] [Related]
9. Distribution of genes encoding virulence factors ompB2, ompCD, ompE, β-lactamase and serotype in pathogenic and colonizing strains of Moraxella catarrhalis.
Mitov IG; Gergova RT; Ouzounova-Raykova VV
Arch Med Res; 2010 Oct; 41(7):530-5. PubMed ID: 21167392
[TBL] [Abstract][Full Text] [Related]
10. Vaccine targets against Moraxella catarrhalis.
Ren D; Pichichero ME
Expert Opin Ther Targets; 2016; 20(1):19-33. PubMed ID: 26565427
[TBL] [Abstract][Full Text] [Related]
11. The role and regulation of Moraxella catarrhalis-induced human beta-defensin 3 expression in human pulmonary epithelial cells.
Haarmann H; Steiner T; Schreiber F; Heinrich A; Zweigner J; N'Guessan PD; Slevogt H
Biochem Biophys Res Commun; 2015 Nov; 467(1):46-52. PubMed ID: 26417692
[TBL] [Abstract][Full Text] [Related]
12. The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.
Wirth T; Morelli G; Kusecek B; van Belkum A; van der Schee C; Meyer A; Achtman M
Genome Res; 2007 Nov; 17(11):1647-56. PubMed ID: 17895425
[TBL] [Abstract][Full Text] [Related]
13. MID and UspA1/A2 of the human respiratory pathogen Moraxella catarrhalis, and interactions with the human host as basis for vaccine development.
Riesbeck K; Tan TT; Forsgren A
Acta Biochim Pol; 2006; 53(3):445-56. PubMed ID: 16964325
[TBL] [Abstract][Full Text] [Related]
14. Moraxella catarrhalis - pathogen or commensal?
Aebi C
Adv Exp Med Biol; 2011; 697():107-16. PubMed ID: 21120723
[TBL] [Abstract][Full Text] [Related]
15. [THE PATHOGENIC POTENTIAL OF MORAXELLA CATARRHALIS AND STAPHYLOCOCCUS EPIDERMIDIS UNDER INFLAMMATORY PROCESSES OF UPPER RESPIRATORY TRACTS].
Kraeva LA; Burgasova OA; Kunilova ES; Petrova IS; Tseneva GY; Bespalova GL
Klin Lab Diagn; 2015 Nov; 60(11):58-61. PubMed ID: 26999868
[TBL] [Abstract][Full Text] [Related]
16. ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence.
Murphy TF; Brauer AL; Johnson A; Kirkham C
PLoS One; 2016; 11(7):e0158689. PubMed ID: 27391026
[TBL] [Abstract][Full Text] [Related]
17. Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding.
Hallström T; Nordström T; Tan TT; Manolov T; Lambris JD; Isenman DE; Zipfel PF; Blom AM; Riesbeck K
J Immunol; 2011 Mar; 186(5):3120-9. PubMed ID: 21270401
[TBL] [Abstract][Full Text] [Related]
18. Moraxella catarrhalis Binds Plasminogen To Evade Host Innate Immunity.
Singh B; Al-Jubair T; Voraganti C; Andersson T; Mukherjee O; Su YC; Zipfel P; Riesbeck K
Infect Immun; 2015 Sep; 83(9):3458-69. PubMed ID: 26099590
[TBL] [Abstract][Full Text] [Related]
19. Short Leucine-Rich Proteoglycans Modulate Complement Activity and Increase Killing of the Respiratory Pathogen
Laabei M; Liu G; Ermert D; Lambris JD; Riesbeck K; Blom AM
J Immunol; 2018 Nov; 201(9):2721-2730. PubMed ID: 30266767
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children.
Ahmed A; Broides A; Givon-Lavi N; Peled N; Dagan R; Greenberg D
Pediatr Infect Dis J; 2008 May; 27(5):459-61. PubMed ID: 18360302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
